Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 05.10.2021.

#TOPRA
#calendar
#regulatoryaffairs
#health
#healthcare
#COVID
#molnupiravir

Healthcare

@emilylmullin shared
On Oct 1, 2021
What if mRNA can deliver cures, not just prevent disease? Its future applications could help dissipate current fears over the technology. Me in @bostonglobe: https://t.co/zJdGnnLtJI
Open
The intriguing next chapter for the tech in COVID vaccines

The intriguing next chapter for the tech in COVID vaccines

Vaccine opponents often express fears about synthetic mRNA. Will future applications of the technology make those concerns fade away?

@matthewherper shared
On Oct 5, 2021
Johnson & Johnson files for boosters. https://t.co/I8ylag8cYq
Open
Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine

Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine

Submission includes data showing a booster increased protection to 94 percent against moderate to severe/critical COVID-19 in the U.S.Substantial increase in immune response when booster ...

@Biotechnology shared
On Sep 30, 2021
AstraZeneca Buys Caelum BioSciences in $500 Million Deal https://t.co/Bsv9mlh0ko https://t.co/JzEDaMwrLB
Open
AstraZeneca Buys Caelum BioSciences in $500 Million Deal

AstraZeneca Buys Caelum BioSciences in $500 Million Deal

AstraZeneca’s Alexion plans to buy all remaining equity in Caelum Biosciences and pick up Caelum’s CAEL-101 in the process.

@BIODeutschland shared
On Oct 4, 2021
"Ukraine's Life Sciences and Healthcare Sector: Recent Developments and Opportunities" October 12, 2021 https://t.co/iCaZ3pdd8c
Open
JCC Ukraine Chapter Webinar

JCC Ukraine Chapter Webinar

Ukraine's Life Sciences and Healthcare Sector: Recent Developments and Opportunities October 12, 2021 (14:00-15:00 CET)

@BIODeutschland shared
On Oct 4, 2021
CTI Announces New Lab Partnership With BioAgilytix https://t.co/KN7MhQpBrX
Open
CTI Announces New Lab Partnership With BioAgilytix

CTI Announces New Lab Partnership With BioAgilytix

Alliance to strengthen both companies' ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle development CTI Clinical …

@TOPRANEWS shared
On Oct 5, 2021
This calendar will provide you with an efficient overview of the wide range of courses and events that we will be offering you in the new year. Download now to view our calendar >> https://t.co/reRaUrS41t #TOPRA #regulatoryaffairs #calendar #healthcare #health https://t.co/CrlQzYDI9G
Open
Professional development

Professional development

Hatfield United Kingdom 20/10/2021 Regulatory Strategy for a New Active Substance: Nonclinical Module 2 of the MSc and Masterclass: This Masterclass will give delegates an …

@sciam shared
On Oct 1, 2021
RT @jfischman: Lots of news this AM about a new pill for #COVID treatment, #molnupiravir, that's looks like it helps sick people. Want to know how it stops the virus? @sciam & @MikeWaldholz explained (when the drug was called EIDD-2801): https://t.co/VsIHoLScO2
Open
New Coronavirus Drug Shows Promise in Animal Tests

New Coronavirus Drug Shows Promise in Animal Tests

Slated for human trials, EIDD-2801 could become the first pill for COVID-19

Read more: Healthcare
weekly 05.10.2021
View archives
Back to home

Subscribe to Biotech Essentials - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech Essentials - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy